【ChiCTR2300068935】Brief Cognitive Behavioural Therapy Mobile Apps for Young Adults in Balinese rural area
ChiCTR2300068935
尚未开始
移动应用程序
/
/
2023-03-01
/
/
Mental health
Brief Cognitive Behavioural Therapy Mobile Apps for Young Adults in Balinese rural area
A Development and Implementation of a Brief Cognitive Behavioural Therapy (B-CBT) Based on Mobile Apps (Bali Sujati) in Overcoming Anxiety in Young Adults in Bali Rural Areas: Mixed Methods Study’s Protocol
81116
This study aims at finding out the potential of the MB-CBT implementation in real-world settings. In the long term this interventional study aimed to investigate the impact of the MB-CBT, while measuring well-being and perceived social support in young adults in Balinese rural areas. The secondary objectives are to evaluate the effectiveness of the MB-CBT in reducing participant-reported anxiety and stress.
随机抽样
Ⅰ期
Participants will be randomized by the built-in algorithm in the mobile app with 1:1 ratio to the intervention and control groups. The algorithm is designed for permuted block randomization where the total number of participants is set prior to the randomization.
/
DIPA Direktorat Riset, Teknologi, dan Pengabdian kepada Masyarakat, Kementerian Pendidikan, Kebudayaan, Riset, dan Teknologi (Ministry of Education, Culture, Research and Technologies in Indonesia) un
/
190;194
/
2023-03-01
2023-12-27
/
The inclusion criteria are indicate good general health, and no recent adverse life events, have access with smartphone and internet use, and have experienced mild anxiety symptoms as assessed via an initial screening tool with GAD-7 score no more than 14 through survey monkey.；
请登录查看The exclusion criteria for participation in this study are having hard hearing, sight and speech problems, having a serious mental disorder, the GAD-7 score more than 14, and refusing to fill in the informed consent form；
请登录查看Universitas Pendidikan Ganesha, Indonesia
81116
Universitas Pendidikan Ganesha, Indonesia的其他临床试验
Universitas Pendidikan Ganesha, Indonesia的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04